Drug intelligence / Profile preview

Sangzhu Yangzheng Yin

Development stage
Unknown
Lead developer
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Sangzhu Yangzheng Yin is a Traditional Chinese Medicine (TCM) herbal formula developed primarily as an adjuvant therapy for gastrointestinal cancers, including colorectal and gastric cancer. The formula is designed to "nourish the upright qi" (Yangzheng) and address the TCM syndrome of "spleen deficiency and dampness-heat," which is commonly observed in patients undergoing chemotherapy. Its primary therapeutic components typically include *Morus alba* (Mulberry leaf/Sang Ye) and *Atractylodes macrocephala* (Bai Zhu), alongside other supportive herbs like *Astragalus* and *Poria*. Research indicates that Sangzhu Yangzheng Yin exerts its effects by modulating the gut microbiota, inhibiting pro-inflammatory signaling pathways such as TLR4/NF-κB, and enhancing systemic immune function. Clinically, it is utilized to improve quality of life, reduce chemotherapy-induced toxicities (such as hand-foot syndrome and gastrointestinal distress), and potentially inhibit tumor progression by altering the tumor microenvironment.

Other names
桑术养正饮Sangzhu Yangzheng Decoction
02

Targets

NF-κBTLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on Sangzhu Yangzheng Yin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sangzhu Yangzheng Yin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call